Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Clinical trial NCT03085056 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03085056
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2026-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.